Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220783938> ?p ?o ?g. }
- W4220783938 endingPage "1721" @default.
- W4220783938 startingPage "1721" @default.
- W4220783938 abstract "Soluble MUC1 has been discussed as a biomarker for predicting prognosis, treatment efficacy, and monitoring disease activity in breast cancer (BC) patients. Most studies in adjuvant settings have used preoperative assessment. This study, part of the SUCCESS-A trial (NCT02181101), assessed the prognostic value of soluble MUC1 before and after standard adjuvant chemotherapy. Patients with high-risk BC were treated within the SUCCESS-A trial with either three cycles of 5-fluorouracil, epirubicin, and cyclophosphamide followed by three cycles of docetaxel or three cycles of FEC followed by three cycles of docetaxel and gemcitabine. Cox regression analyses were performed to investigate the prognostic value of CA27.29 before and after chemotherapy relative to disease-free survival (DFS), along with established BC prognostic factors such as age, body mass index, tumor size, nodal status, estrogen receptor, progesterone receptor, HER2 status, and grading. Pre-chemotherapy and post-chemotherapy CA27.29 assessments were available for 2687 patients of 3754 randomized patients. Pre-chemotherapy CA27.29 assessment was associated with DFS in addition to established prognostic factors. It had no prognostic value in node-negative patients, but there was a clear association in node-positive patients. Post-chemotherapy CA27.29 assessment did not add any prognostic value, either on its own or in addition to pre-chemotherapy CA27.29 assessment." @default.
- W4220783938 created "2022-04-03" @default.
- W4220783938 creator A5003665481 @default.
- W4220783938 creator A5008649645 @default.
- W4220783938 creator A5017728105 @default.
- W4220783938 creator A5023008141 @default.
- W4220783938 creator A5024741688 @default.
- W4220783938 creator A5031064268 @default.
- W4220783938 creator A5036608852 @default.
- W4220783938 creator A5038957171 @default.
- W4220783938 creator A5039816488 @default.
- W4220783938 creator A5040637036 @default.
- W4220783938 creator A5040883843 @default.
- W4220783938 creator A5044421523 @default.
- W4220783938 creator A5045891981 @default.
- W4220783938 creator A5047757604 @default.
- W4220783938 creator A5052040947 @default.
- W4220783938 creator A5052269870 @default.
- W4220783938 creator A5056412323 @default.
- W4220783938 creator A5072762948 @default.
- W4220783938 creator A5081829270 @default.
- W4220783938 creator A5085341927 @default.
- W4220783938 creator A5086791040 @default.
- W4220783938 creator A5088637879 @default.
- W4220783938 creator A5089392438 @default.
- W4220783938 date "2022-03-28" @default.
- W4220783938 modified "2023-10-03" @default.
- W4220783938 title "MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients" @default.
- W4220783938 cites W167672472 @default.
- W4220783938 cites W1798247406 @default.
- W4220783938 cites W1863700672 @default.
- W4220783938 cites W1965781424 @default.
- W4220783938 cites W1966714873 @default.
- W4220783938 cites W1968813883 @default.
- W4220783938 cites W1987424755 @default.
- W4220783938 cites W1999014818 @default.
- W4220783938 cites W2000916902 @default.
- W4220783938 cites W2016364907 @default.
- W4220783938 cites W2017495882 @default.
- W4220783938 cites W2020016182 @default.
- W4220783938 cites W2020256830 @default.
- W4220783938 cites W2024651858 @default.
- W4220783938 cites W2031257280 @default.
- W4220783938 cites W2034451570 @default.
- W4220783938 cites W2048068610 @default.
- W4220783938 cites W2050044556 @default.
- W4220783938 cites W2053059448 @default.
- W4220783938 cites W2065236043 @default.
- W4220783938 cites W20799819 @default.
- W4220783938 cites W2082174016 @default.
- W4220783938 cites W2089625847 @default.
- W4220783938 cites W2092190065 @default.
- W4220783938 cites W2110066719 @default.
- W4220783938 cites W2120628328 @default.
- W4220783938 cites W2129384532 @default.
- W4220783938 cites W2142303329 @default.
- W4220783938 cites W2146421261 @default.
- W4220783938 cites W2153766359 @default.
- W4220783938 cites W2156081141 @default.
- W4220783938 cites W2157355630 @default.
- W4220783938 cites W2157367015 @default.
- W4220783938 cites W2169793514 @default.
- W4220783938 cites W2324292370 @default.
- W4220783938 cites W2436894298 @default.
- W4220783938 cites W2480252091 @default.
- W4220783938 cites W254716823 @default.
- W4220783938 cites W2749309410 @default.
- W4220783938 cites W2888952165 @default.
- W4220783938 cites W2896378740 @default.
- W4220783938 cites W2940919039 @default.
- W4220783938 cites W2996758988 @default.
- W4220783938 cites W3094271383 @default.
- W4220783938 cites W3143843487 @default.
- W4220783938 cites W846701328 @default.
- W4220783938 cites W2407182056 @default.
- W4220783938 cites W2416048253 @default.
- W4220783938 cites W43766594 @default.
- W4220783938 doi "https://doi.org/10.3390/cancers14071721" @default.
- W4220783938 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35406491" @default.
- W4220783938 hasPublicationYear "2022" @default.
- W4220783938 type Work @default.
- W4220783938 citedByCount "4" @default.
- W4220783938 countsByYear W42207839382023 @default.
- W4220783938 crossrefType "journal-article" @default.
- W4220783938 hasAuthorship W4220783938A5003665481 @default.
- W4220783938 hasAuthorship W4220783938A5008649645 @default.
- W4220783938 hasAuthorship W4220783938A5017728105 @default.
- W4220783938 hasAuthorship W4220783938A5023008141 @default.
- W4220783938 hasAuthorship W4220783938A5024741688 @default.
- W4220783938 hasAuthorship W4220783938A5031064268 @default.
- W4220783938 hasAuthorship W4220783938A5036608852 @default.
- W4220783938 hasAuthorship W4220783938A5038957171 @default.
- W4220783938 hasAuthorship W4220783938A5039816488 @default.
- W4220783938 hasAuthorship W4220783938A5040637036 @default.
- W4220783938 hasAuthorship W4220783938A5040883843 @default.
- W4220783938 hasAuthorship W4220783938A5044421523 @default.
- W4220783938 hasAuthorship W4220783938A5045891981 @default.
- W4220783938 hasAuthorship W4220783938A5047757604 @default.